Disease State

Lung Cancer

Title

Critical Insights on Mutant-Specific Epidermal Growth Factor Receptor Inhibitors for NSCLC - Denver, CO

Event Date/Time

Monday, September 7, 2015 | 6:00 PM - 8:00 PM

Location

Location

Colorado Convention Center - Room 601/603
700 14th Street
Denver, CO 80202
United States

Faculty

Faculty

Edward S. Kim, MD - Chair
Chair, Solid Tumor Oncology and Investigational Therapeutics
Donald S. Kim Distinguished Chair for Cancer Research
Levine Cancer Institute
Carolinas HealthCare System
Charlotte, North Carolina

David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Director, Thoracic Oncology Program
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, California

Jonathan Goldman, MD
Assistant Professor, UCLA Hematology & Oncology
Associate Director of Drug Development
Director of Clinical Trials in Thoracic Oncology
University of California Los Angeles
Santa Monica, California

Lecia V. Sequist, MD, MPH
Associate Professor, Department of Medicine
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

Target Audience

The target audience for this activity is medical oncologists, hematologist/oncologists, surgeons, radiation oncologists, pathologists, oncology pharmacists, oncology nurses, and other allied healthcare professionals caring for patients with NSCLC.

Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Describe mechanisms of tumor resistance to EGFR tyrosine kinase inhibitors in NSCLC
  • Critically analyze emerging data on the efficacy and safety currently available and emerging targeted therapies to circumvent acquired EGFR-TKI resistance in T790M-mutant NSCLC
  • Recall recent clinical trial data on emerging immunotherapies alone or in combination with currently available and emerging targeted therapies for T790M-mutant NSCLC
  • Increase awareness of recent and ongoing clinical trials in patients with advanced NSCLC with acquired EGFR-TKI resistance

 

PHYSICIAN CONTINUING EDUCATION

PHYSICIAN CONTINUING EDUCATION

Accreditation Statement
Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Educational Concepts Group, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACIST CONTINUING EDUCATION

PHARMACIST CONTINUING EDUCATION

Educational Concepts Group, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Educational Concepts Group, LLC designates this continuing education activity for 1.5 contact hours (0.15 CEUs) (UAN 0199-0000-15-016-L01-P).

Type of activity: Application-based

CME/CE CREDIT

There are no fees for participating and receiving CME/CE credits for this activity. Participants who complete an activity evaluation form and return it to Educational Concepts Group, LLC may view and print their credit letter or statement of credit via the website, www.ecgcme.com, 6 weeks after the activity.

FACULTY DISCLOSURE STATEMENT

FACULTY DISCLOSURE STATEMENT

All faculty participating in continuing education activities provided by ECG are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.

REGISTRATION DETAILS

REGISTRATION DETAILS

Registration before Wednesday, September 2, 2015 is requested. You will receive confirmation of your registration by e-mail. On-site registration is limited to space availability.

REGISTRATION FEE: NONE

Questions?

Please contact Patti Bunyasaranand at Educational Concepts Group, LLC
Phone: 1.844.814.6451 | Fax: 1.404.994.2779 | Contact Us

AMERICANS WITH DISABILITIES ACT (ADA)

AMERICANS WITH DISABILITIES ACT (ADA)

ECG staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Patti Bunyasaranand prior to the live event at 1.844.814.6451.

This activity is provided by Educational Concepts Group, LLC.

This activity is supported by an independent educational grant from Clovis Oncology.

This activity was approved by the 16th World Conference on Lung Cancer Program Committee as an independent activity held in conjunction with the 16th World Conference on Lung Cancer. This presentation is not sponsored or endorsed by IASLC.